scorecardresearch
Friday, March 29, 2024
TopicBharat Biotech

Topic: Bharat Biotech

Several immunisation drives hit, Union govt prods Bharat Biotech over ‘delay’ in vaccine supplies

Health ministry points at shortfall in supply of 3 vaccines, for Japanese Encephalitis, Hepatitis B & rotavirus. It also sought reason for delay in letter to Bharat Biotech.

World’s 1st Covid nasal vaccine by Bharat Biotech to launch on R-Day, says founder Krishna Ella

Speaking at International Science Festival in Bhopal, Krishna Ella said iNCOVACC will be launched by 26 Jan and a vaccine for lumpy skin disease, too, will be launched next month.

Bharat Biotech’s Covid nasal vaccine to be sold for Rs 325 at govt hospitals, Rs 800 at private

The Union health ministry said that those who have previously taken Covishield and Covaxin could take the nasal vaccine as a heterologous booster dose.

Bharat Biotech’s booster nasal vaccine on CoWIN from today as India strengthens Covid response

Official sources clarifeid that masks were not mandatory yet. Congress’s Bharat Jodo Yatra can also continue provided it adhered to Covid protocols, they said.

‘Fake news’ — Bharat Biotech, govt deny report on ‘discrepancies’ in Covaxin trial data

Medical news site STAT had cited internal documents to allege that Bharat Biotech had taken ‘questionable’ steps under political pressure to speed up development of Covaxin.

Drug authority clears use of India’s first nasal Covid-19 vaccine made by Bharat Biotech

The Covaxin maker’s nasal shot will be used in emergency situations for the 18+ age group, Union Health Minister Mansukh Mandaviya tweeted.

WHO move to suspend Covaxin’s UN supply won’t affect trips to UK, US & over 90 nations, govt says

Bharat Biotech is believed to have assured Government of India that it will ‘quickly’ reply to WHO about ‘deficiencies found in its manufacturing’ during an inspection last month.

DCGI gives emergency use approval to Biological E’s Corbevax vaccine for kids aged 12-18

It is the second Covid vaccine to get approval for use in children in India after Bharat Biotech's Covaxin.

ICMR received Rs 171.74 cr in royalty from sale of Covaxin till 31 Jan, govt tells Rajya Sabha

ICMR and Bharat Biotech developed Covaxin together, and MoS Health Bharati Pawar says in written reply that the research body spent Rs 35 crore on its development.

Bharat Biotech gets DCGI’s nod to conduct ​clinical trials of intranasal Covid vaccine BBV154

The dosage form of the vaccine is liquid, containing 0.5ml/per dose for the intranasal route of administration. The trials will take place at nine different sites of the country.

On Camera

Profit margins in lottery industry are tiny. Here’s how Future Gaming paid for its electoral bonds

Neither state govts nor companies earn large profits from lotteries. However, a look at the system shows there’s ample evidence of murky dealings and financial irregularities. 

Amid plans to lift AFSPA, Army starts joint training with Jammu & Kashmir Police

In an interview with Gulistan News this week, Union Home Minister Amit Shah said the government would leave law and order to J&K Police and slowly withdraw troops.

For BJP, Kejriwal is an idea whose time has come to be destroyed

The ‘idea’ Kejriwal's politics grew around was a no-holds-barred fight against corruption. That is the reason Modi govt has now tarred him and his entire party with the same paint.